Evidence-Based Medicine for Mental Health?
Less trial and error. More clinical assurance. Better patient outcomes.
If you’re a healthcare provider treating mental health conditions like depression, anxiety, bipolar disorder, ADHD and PTSD, you now have a scientific tool that can assist your clinical decision-making and ensure better mental healthcare for your patients.
Determining which psychotropic medications will work best for your patients.
MYnd Analytics’ cloud-based Psychiatric EEG Evaluation Registry (PEER) enables you to review outcome data related to your patient’s unique neurophysiology and prescribe the medication with the greatest likelihood of success. Our exclusive technology may dramatically improvs the efficacy of mental health medications, simply by matching the right therapies to your patients’ individual brain patterns.
Bypassing the frustration of trial-and-error prescribing.
The PEER Report shows what medications worked or didn’t work for people with similar brainwaves to your patient, so you can identify the likely mental health prescription response and prescribe the most promising medication first.
Earning and maintaining the confidence of your patients.
Surveys show that patients think more highly of physicians who are informed by personalized information. The PEER Report supplies the data necessary for healthcare providers to use personalized, evidence-based data to help make the best clinical decisions.
Does PEER really work? Yes.
In pooled results of four Randomized Controlled Studies, medication efficacy tripled in patients on PEER-guided treatment vs. treatment as usual (47% vs. 16%, respectively) for patients with treatment-resistant depression.
Treatment as Usual
MEAN CHANGED FROM THE BASELINE QUIDS
In randomized placebo controlled studies conducted at Walter Reed Military Hospital, results of PEER-guided treatment showed:
- 144% improvement in depression scores
- 75% improvement in Suicidality scores
- 139% improvement in PTSD scores (compared to traditional treatment without PEER data)
- Patients stayed in treatment 2.5 times longer than with trial and error